Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study
Status:
RECRUITING
Trial end date:
2025-07-30
Target enrollment:
Participant gender:
Summary
The main aim of the present study is to investigate the effects of orally administered vasopressin (AVP) on the perception of time-to-collision of threatening and non-threatening stimuli by combining a validated looming fear eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design.
Phase:
NA
Details
Lead Sponsor:
University of Electronic Science and Technology of China